XML 29 R17.htm IDEA: XBRL DOCUMENT

SEGMENT REPORTING (Tables)

3 Months Ended

Mar. 31, 2015

5. SEGMENT REPORTING

The Company is comprised of two reportable segments, Core Companion Animal Health ("CCA") and Other Vaccines, Pharmaceuticals and Products ("OVP"). The Core Companion Animal Health segment includes diagnostic instruments and supplies, as well as single use diagnostic and other tests and pharmaceuticals. The CCA segment also includes digital radiography and ultrasound products along with embedded software and support, data hosting and other services from Heska Imaging. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The Other Vaccines, Pharmaceuticals and Products segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.

Summarized financial information concerning the Company's reportable segments is shown in the following table (in thousands):

		Core Companion Animal Health				Other Vaccines, Pharmaceuticals and Products	Total
Three Months Ended March 31, 2014:
	Total revenue	$	17,366		$	3,427	$	20,793
	Operating income (loss)		(308	)		207		(101	)
	Interest expense		37			13		50
	Total assets		80,839			13,187		94,026
	Net assets		41,484			4,606		46,090
	Capital expenditures		1,211			106		1,317
	Depreciation and amortization		543			186		729

Three Months Ended March 31, 2015:
	Total revenue	$	19,572		$	3,322	$	22,894
	Operating income (loss)		535			486		1,021
	Interest expense		40			12		52
	Total assets		86,921			13,431		100,352
	Net assets		48,966			5,311		54,277
	Capital expenditures		307			298		605
	Depreciation and amortization		830			176		1,006